Phibro Animal Health (PAHC) Enterprise Value (2014 - 2026)

Phibro Animal Health has reported Enterprise Value for 13 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 24.37% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 24.37% increase from a year earlier, with the FY2026 full-year figure at $1.2 billion, up 24.37% from the prior year.
• Enterprise Value was $1.2 billion for Q2 2026 at Phibro Animal Health, down from $2.2 billion in the prior quarter.
• The five-year high for Enterprise Value was $2.2 billion in Q1 2026, with the low at $376.5 million in Q4 2023.
• Average Enterprise Value over 5 years is $824.1 million, with a median of $699.4 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 41.7% in 2022, then surged 172.33% in 2026.
• Over 5 years, Enterprise Value stood at $464.7 million in 2022, then declined by 18.98% to $376.5 million in 2023, then jumped by 108.08% to $783.5 million in 2024, then jumped by 83.77% to $1.4 billion in 2025, then decreased by 17.27% to $1.2 billion in 2026.
• The last three Enterprise Value figures came in at $1.2 billion (Q2 2026), $2.2 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.